Crystalline form of a proteasome inhibitor
US10072029B2 · kind B2 · utility
0Cited by
0References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 10, 2016 |
| Grant date | Sep 11, 2018 |
| Priority date | — |
| Expiry date | Feb 10, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to a novel crystalline form of a proteasome inhibitor, and to the processes for the preparation thereof. The novel crystalline form according to the disclosure may be used in the preparation of pharmaceutical compositions for the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.